RICCARDI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 723
EU - Europa 503
AS - Asia 128
AF - Africa 24
SA - Sud America 1
Totale 1.379
Nazione #
US - Stati Uniti d'America 715
IT - Italia 375
CN - Cina 68
VN - Vietnam 40
NL - Olanda 29
CI - Costa d'Avorio 23
DE - Germania 18
IE - Irlanda 16
BE - Belgio 10
FR - Francia 10
ES - Italia 9
FI - Finlandia 9
SE - Svezia 9
CA - Canada 8
GB - Regno Unito 7
HK - Hong Kong 6
IN - India 5
GR - Grecia 4
CZ - Repubblica Ceca 2
JP - Giappone 2
RO - Romania 2
SY - Repubblica araba siriana 2
BR - Brasile 1
EG - Egitto 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SG - Singapore 1
SI - Slovenia 1
TR - Turchia 1
Totale 1.379
Città #
Chandler 186
Napoli 96
Ashburn 63
Naples 56
Dong Ket 40
Millbury 36
Beijing 26
Lawrence 25
Des Moines 24
Amsterdam 23
Nanjing 21
Boston 18
Milan 14
Rome 14
Princeton 12
Wilmington 10
Madrid 9
Redwood City 8
Brussels 7
Ottawa 7
Torre del Greco 7
Houston 6
Norwalk 6
Salerno 6
Caserta 5
Fairfield 5
Woodbridge 5
Cinisello Balsamo 4
Forlì 4
Hong Kong 4
Jiaxing 4
Nanchang 4
Pune 4
Bologna 3
Cava de' Tirreni 3
Fisciano 3
Guangzhou 3
Kronberg 3
Lappeenranta 3
Portici 3
Seattle 3
Shenyang 3
Stockholm 3
Trento 3
Werchter 3
Caivano 2
Cardito 2
Casalbordino 2
Changsha 2
Council Bluffs 2
Erlangen 2
Fontanarosa 2
Hebei 2
Hung Hom 2
Letovice 2
Nuremberg 2
Padula 2
Pozzuoli 2
San Giorgio Del Sannio 2
Stella Cilento 2
Torre Annunziata 2
Trieste 2
Villar Focchiardo 2
Aachen 1
Avola 1
Belgrade 1
Boardman 1
Bordighera 1
Bruneck 1
Cambridge 1
Capua 1
Cava De' Tirreni 1
Chengdu 1
Cologne 1
Corleto Perticara 1
Dietzenbach 1
Dortmund 1
Erice 1
Florence 1
Fremont 1
Giungano 1
Hassan Abdal 1
Iasi 1
Indiana 1
La Jolla 1
Leiden 1
Little Rock 1
Ljubljana 1
Marano di Napoli 1
Medicina 1
Modena 1
Mogi Guacu 1
Mugnano di Napoli 1
Nagold 1
Nocera Inferiore 1
Ottaviano 1
Parma 1
Pontelandolfo 1
Quarto 1
Rende 1
Totale 868
Nome #
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 72
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 70
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 64
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 57
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 57
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 53
Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity 51
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 50
Stability is not everything the case of the cyclization of the thrombin binding aptamer 49
Synthesis, antiproliferative activity, and DNA binding studies of nucleoamino acid-containing Pt(II) complexes 48
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 46
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 45
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 44
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 43
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 39
Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies 38
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 37
Affinity chromatography-based assays for the screening of potential ligands selective for G-quadruplex structures 35
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 34
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 32
AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies 31
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 31
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 29
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 29
G-quadruplex-based aptamers targeting human thrombin: Discovery, chemical modifications and antithrombotic effects 29
Fine-tuning the properties of the thrombin binding aptamer through cyclization: Effect of the 5′-3′ connecting linker on the aptamer stability and anticoagulant activity 28
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 26
Natural compounds from Juncus plants interacting with telomeric and oncogene G-quadruplex structures as potential anticancer agents 25
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 24
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! 23
Exploring the Binding of Natural Compounds to Cancer-Related G-Quadruplex Structures: From 9,10-Dihydrophenanthrenes to Their Dimeric and Glucoside Derivatives 22
RuIII Complexes for Anticancer Therapy: The Importance of Being Nucleolipidic 22
Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection 21
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 19
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 18
Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases 17
Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems 16
Charge-transfer interactions stabilize g-quadruplex-forming thrombin binding aptamers and can improve their anticoagulant activity 16
Design, synthesis and characterization of cyclic nu172 analogues: A biophysical and biological insight 15
Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition 14
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 14
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers 13
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 12
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 11
Synthesis and characterization of multifunctional nanovesicles composed of POPC lipid molecules for nuclear imaging 9
Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems 6
Modular symmetric ligands for selective recognition of cancer-relevant G-quadruplexes 6
Probing naphthalene diimide and 3-hydroxypropylphosphate as end-conjugating moieties for improved thrombin binding aptamers: Structural and biological effects 5
Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study 4
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 2
Metal-Based Complexes in Cancer 1
Totale 1.502
Categoria #
all - tutte 5.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.828


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201929 0 0 0 0 0 0 0 0 0 0 21 8
2019/2020185 40 3 17 12 23 4 10 8 27 16 21 4
2020/2021134 3 1 3 11 16 12 4 2 23 16 1 42
2021/2022234 0 0 1 7 5 7 7 10 37 10 66 84
2022/2023471 45 51 8 31 52 51 14 51 68 47 37 16
2023/2024257 11 68 43 27 17 26 24 34 4 0 3 0
Totale 1.502